Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

NCT05897294 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Invasive Pulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Chronic Pulmonary Aspergillosis
Aspergillus Tracheobronchitis
Anastomotic Infection
Pulmonary Fungal Infection

Interventions

DRUG: Voriconazole Inhalation Powder

Sponsor

TFF Pharmaceuticals, Inc.